Authors: Sabine de Wild1, Linda de Munck2, Janneke Verloop2, Thijs van Dalen3, Paula Elkhuizen4, Ruud Houben5, Elise van Leeuwen6, Sabine Linn7, Ruud Pijnappel8, Philip Poortmans9, Luc Strobbe10, Jelle Wesseling11, Adri Voogd2,12, Liesbeth Boersma5
1Maastricht University Medical Centre+, Dept. of Surgery, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands; 2Netherlands Comprehensive Cancer Organisation, Dept. of Research and Development, Utrecht, The Netherlands; 3Diakonessen Hospital, Dept. of Surgery, Utrecht, The Netherlands; 4Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Dept. of Radiation Oncology, Amsterdam, The Netherlands; 5Maastricht University Medical Centre+, Dept. of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands; 6Dutch Breast Cancer Research Group, BOOG, Amsterdam, The Netherlands; 7Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Dept. of Medical Oncology, Amsterdam, The Netherlands; 8University Medical Centre Utrecht, Dept. of Radiology, Utrecht, The Netherlands; 9Iridium Network, Antwerp University, Dept. of Radiation Oncology, Antwerp, Belgium; 10Canisius Wilhelmina Hospital, Dept. of Surgery, Nijmegen, The Netherlands; 11Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Dept. of Pathology, Amsterdam, The Netherlands; 12Maastricht University Medical Centre+, Dept. of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands
Show Affiliations
Hide Affiliations